Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.
Raffaella VitiAndrea MarcellusiAlessandro CaponeAndrea MatucciAlessandra VultaggioClaudio PignataGiuseppe SpadaroAngelo VaccaCarolina MarascoCarlo AgostiniFrancesco Saverio MenniniPublished in: Clinical drug investigation (2018)
This information provides a comprehensive perspective of the economic issues, and facilitates better-informed public health decision making, in the management of CVID and XLA in Italy.